•Investment attraction: Meetings with investors and pitch deck presentations for $2 million.

•Prototyping: Completing the initial version of the microfluidic chip and MR detector. Verification of sequence accuracy up to 95% for 50-500 nucleotides.

•Patenting: Preparation and filing of a full patent for the technology.

•Market entry: Initial sales to universities and research laboratories. Marketing: Promotional campaign under the Singulorize brand.

•Production expansion and International market entry: Mass production of devices and supply of consumables. Launch of a software subscription service (initially $5,000/year).

•Full-scale trials: Tests for DNA sequence analysis at the chromosome level. Device optimization, development of the final version of the Janus Q1 design (black cube, 50x50x50 cm).

Our goal is to reach $5 million in revenue within 3 years.